Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction - PubMed (original) (raw)
Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction
A Hamsten et al. N Engl J Med. 1985.
Abstract
Certain risk factors for myocardial infarction have been linked with disturbances in fibrinolytic activity. The recent development in our laboratory of new sensitive and specific methods for determination of tissue plasminogen activator (t-PA) activity and antigen, as well as the discovery of a new rapid inhibitor of this enzyme, enabled us to study fibrinolytic function in detail in a representative population of postinfarction patients. Seventy-one patients (62 men and 9 women) who had survived a myocardial infarction before the age of 45 were compared with 50 healthy subjects of similar age, three years after the infarction. Low t-PA activity after venous occlusion, mostly explained by high plasma levels of the t-PA inhibitor and to some extent by impaired release of t-PA from the vessel wall, was a frequent finding in the patients. The level of t-PA inhibitor was positively and significantly correlated with levels of serum triglycerides. Our data suggest that reduced fibrinolytic capacity due to increased plasma levels of a rapid inhibitor of t-PA may have pathogenetic importance in myocardial infarction, particularly in patients with hypertriglyceridemia.
Similar articles
- Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
Sebestjen M, Zegura B, Guzic-Salobir B, Keber I. Sebestjen M, et al. Wien Klin Wochenschr. 2001 Feb 15;113(3-4):113-8. Wien Klin Wochenschr. 2001. PMID: 11253736 - [Plasminogen activator of tissue type. Physiology, pathophysiology and clinical value].
Korninger C. Korninger C. Wien Klin Wochenschr. 1985 Nov 22;97(22):832-40. Wien Klin Wochenschr. 1985. PMID: 2934899 Review. German.
Cited by
- Plasminogen Activation Inhibitor-1 Promotes Resilience to Acute Oxidative Stress in Cerebral Arteries from Females.
Safa, Norton CE. Safa, et al. Pharmaceuticals (Basel). 2024 Sep 14;17(9):1210. doi: 10.3390/ph17091210. Pharmaceuticals (Basel). 2024. PMID: 39338372 Free PMC article. - Blood PAI-1 and cardiovascular and metabolic risk factors among the middle-aged women from SWAN study.
Xu Z, Huang Y. Xu Z, et al. Sci Rep. 2024 Sep 11;14(1):21207. doi: 10.1038/s41598-024-71908-z. Sci Rep. 2024. PMID: 39261530 Free PMC article. - Connecting impaired fibrinolysis and dyslipidemia.
Rodriguez M, Zheng Z. Rodriguez M, et al. Res Pract Thromb Haemost. 2024 Apr 5;8(3):102394. doi: 10.1016/j.rpth.2024.102394. eCollection 2024 Mar. Res Pract Thromb Haemost. 2024. PMID: 38706781 Free PMC article. - Determinants of Endogenous Fibrinolysis in Whole Blood Under High Shear in Patients With Myocardial Infarction.
Kanji R, Gue YX, Farag MF, Spencer NH, Mutch NJ, Gorog DA. Kanji R, et al. JACC Basic Transl Sci. 2022 Aug 24;7(11):1069-1082. doi: 10.1016/j.jacbts.2022.05.007. eCollection 2022 Nov. JACC Basic Transl Sci. 2022. PMID: 36687271 Free PMC article. - Hypertriglyceridemia and Atherosclerotic Carotid Artery Stenosis.
Miura Y, Suzuki H. Miura Y, et al. Int J Mol Sci. 2022 Dec 19;23(24):16224. doi: 10.3390/ijms232416224. Int J Mol Sci. 2022. PMID: 36555866 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical